Business

Director Dealing

Director Dealing.

articleCrism Therapeutics CorporationApril 7, 20255/company/crism-therapeutics-corporation/news/director-dealing-170
Director Dealing

About this update from Crism Therapeutics Corporation

[{"type":"text","content":"\n\n7 April 2025\n \nCRISM Therapeutics Corporation\n(AIM:CRTX)\n \nDirector Dealing\n \nCRISM Therapeutics Corporation (\"CRISM\" or the \"Company\") announces that it has been notified that Non-Executive Director, Gerald Beaney has purchased 20,182 ordinary shares of the Company at a price of 9.88 pence per share.\n \nFollowing this purchase, Mr Beaney holds 45,182 ordinary shares, which represents approximately 0.14% of the Company's total issued share capital of 32,678,312.\n \n \nEnquiries:\n \n\n\n\n\nCompany\n\n\nNomad and Broker\n\n\nFinancial PR\n\n\n\n\nCRISM Therapeutics Corporation\n\n\nS.P. Angel Corporate Finance LLP\n\n\nBuchanan\n\n\n\n\nAndrew Webb, CEO\nChris McConville, CSO\n\n\nRichard Morrison\nAdam Cowl\n\n\n \nMark Court [email protected]\nJamie Hooper [email protected]\n\n\n\n\nvia Buchanan\n\n\n+44 (0) 20 3470 0470\n\n\n+44 (0) 20 7466 5000\n\n\n\n\n \n \n \nDealings by Persons Discharging Managerial Responsibilities\n \n\n\n\n\n 1\n \n\n\nDetails of the person discharging managerial responsibilities / person closely associated\n \n\n\n\n\na)\n \n\n\nName\n\n\nGerald Beaney\n\n\n\n\n2\n \n\n\nReason for the notification\n \n\n\n\n\na)\n \n\n\nPosition/status\n\n\nNon-Executive Director\n\n\n\n\nb)\n \n\n\nInitial notification /Amendment\n\n\n Initial Notification\n\n\n\n\n3\n \n\n\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n\n\n\n\na)\n \n\n\nName\n\n\n CRISM Therapeutics Corporation\n\n\n\n\nb)\n \n\n\nLEI\n \n\n\n213800XFW6MKVCHHPW88\n \n \n\n\n\n\n4\n \n\n\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n\n\n\n\na)\n \n\n\nDescription of the financial instrument, type of instrument\n\n\nOrdinary shares with no par value\n\n\n\n\n\n\n\n\n\n\n\n\nIdentification code\n\n\nISIN: VGG042401262\n \n\n\n\n\n\n\n\n\n\n\n\n\nb)\n \n\n\nNature of the transaction\n \n\n\nPurchase of shares\n\n\n\n\nc)\n \n\n\nPrice(s) and volume(s)\n\n\n \n \n \n\n\n \n\n\n\n\nDirector/PDMR\n\n\nPrice\n\n...

More updates from Crism Therapeutics Corporation